Inclusion of PF68 Surfactant Improves Stability of rAAV Titer when Passed through a Surgical Device Used in Retinal Gene Therapy
Recent advances in recombinant adeno-associated virus (rAAV) gene therapy for choroideremia show gene replacement to be a promising approach. It is, however, well known that contact of vector solution with plastic materials in the surgical device may result in non-specific adsorption with resulting...
Main Authors: | Maria I. Patrício, Christopher I. Cox, Clare Blue, Alun R. Barnard, Cristina Martinez-Fernandez de la Camara, Robert E. MacLaren |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-06-01
|
Series: | Molecular Therapy: Methods & Clinical Development |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2329050119301305 |
Similar Items
-
Robust Long-term Transduction of Common Marmoset Neuromuscular Tissue With rAAV1 and rAAV9
by: Hironori Okada, et al.
Published: (2013-01-01) -
Monobac System–A Single Baculovirus for the Production of rAAV
by: Lionel Galibert, et al.
Published: (2021-08-01) -
Molecular Therapies for Choroideremia
by: Jasmina Cehajic Kapetanovic, et al.
Published: (2019-09-01) -
Outcome of Full-Thickness Macular Hole Surgery in Choroideremia
by: Mays Talib, et al.
Published: (2017-07-01) -
Recombinant Adeno-Associated Virus Serotype 6 (rAAV6) Potently and Preferentially Transduces Rat Astrocytes in vitro and in vivo
by: Alexandra L. Schober, et al.
Published: (2016-11-01)